Clinical spectrum of connective tissue disorders

Journal, Indian Academy of Clinical Medicine

Volumn 7, Issue 3, 2006, Pages 217-224

  Owlia, Mohammad Bagher ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; CARDIOVASCULAR DISEASE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEMATOLOGIC DISEASE; KIDNEY DISEASE; LUNG DISEASE; MUSCULOSKELETAL DISEASE; PLEURISY; PREVALENCE; REVIEW; RHEUMATIC DISEASE; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33748869513     PISSN: 09723560     EISSN: 09723560     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Luthra HS. Oxford text book of rheumatology. Maddison PJ, Isenberg DA, Woo P, Glass DN. New York, Oxford University Press, 1998; 1999: 1202.
2. Walker-Bone K, Cooper C. The spectrum of inflammatory rheumatic disorders. Baillieres Best Pract Res Clin Rheumatol 2000; 14 (3): 425-44.
3. Woolf AD. Specialist training in rheumatology in Europe. Rheumatology (Oxford) 2002; 41 (9): 1062-6.
4. Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 2002; 14 (2): 121-6.
5. Glazier R, Fry J, Badley E. Arthritis and rheumatism are neglected health priorities: a bibliometric study. J Rheumatol 2001; 28 (4): 706-11.
6. Feletar M, Littlejohn G. The value of clinical signs in rheumatology. Aust Fam Physician 1999; 28 (12): 1223-7.
7. Gran JT, Nordvag BY. Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol 2000; 19 (6): 450-4.
8. Hood C, Johnson J, Kelly C. What is the prevalence of rheumatic disorders in general medical inpatients? Postgrad Med J 2001; 77 (914): 774-7.
9. Woolf AD. How to assess musculoskeletal conditions. History and physical examination. Best Pract Res Clin Rheumatol 2003; 17 (3): 381-402.
10. Clemens LE. The role of the rheumatologist in managing arthritis. Med J Aust 2001; 175 Suppl: S97-101.
11. El-Gabalawy H. Common denominators of inflammatory joint diseases. J Rheumatol Suppl 2005; 72: 3-6.
12. Daoud KF, Barkhuizen A. Rheumatic mimics and selected triggers of fibromyalgia. Curr Pain Headache Rep 2002; 6 (4): 284-8.
13. Boumpas DT, Austin HA, III, Fessler BJ et al. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and haematologic disease. Ann Intern Med 1995; 122 (12): 940-50.
14. Fioravanti A, Montemerani M, Scola C et al. Fever of unknown origin in rheumatology. Recenti Prog Med 1998; 89 (1): 30-6.
15. Bevra Hannahs Hahn, Bruce C Gilliland. Systemic lupus erythematous, sytemic sclerosis and related disorders. In: Kurt J.Isselbacher, Antony S.Fauci, ed. Harrison's Principles of internal medicine. Philadelphia: McGraw-Hill, 2005; 1960-90.
16. Hood C, Johnson J, Kelly C. What is the prevalence of rheumatic disorders in general medical inpatients? Postgrad Med J 2001; 77 (914): 774-7.
17. Brecher LS. Arthritis is a term used to describe more than 100 different rheumatic diseases. J Am Osteopath Assoc 2001; 101 (4 Suppl Pt 2): inside.
18. Cervera R, Asherson RA, Acevedo ML et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004; 63 (10): 1312-7.
19. Steven M.Edworthy. Clinical manifestation of SLE. Kelley's text book of rheumatology. Philadelphia: Elsevier Saunders, 2005; 1207-17.
20. Michel F, Navellou JC, Ferraud D, Toussirot E, Wendling D. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine 2005; 72 (1): 82-5.
21. DeAR, Del MP, Blasetti P, Cervini C. Raynaud's phenomenon: clinical spectrum of 118 patients. Clin Rheumatol 2003; 22 (4-5): 279-84.
22. Munther A Khamashta, Maria J. Cuadrado GRH. Antiphospjholipid syndrome, clinical features. Rhem Dis Clin of North America 2001; 27 (3): 507-24.
23. Akil M, Amos RS. ABC of Rheumatology: Rheumatoid arthritis-I: clinical features and diagnosis. BMJ 1995; 310 (6979): 587-90.
24. Harris-Stith R, Erickson QL, Elston DM, vid-Bajar K. Bullous eruption: a manifestation of lupus erythematosus. Cutis 2003; 72 (1): 31-7.
25. Steven M. Edworthy. Clinical manifestations of systemic lupus erythematosus. Kelley's text book of rheumatology. Philadelphia: Elsevier Saunders, 2005; 1207-17.
26. Jerrold S, Levine WBJR. The antiphospholipid syndrome. N Engl J Med 2002; 346 (10): 752-61.
27. Fam AG. Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol 2000; 14 (3): 515-33.
28. Lange U, Strunk J. Cardiovascular manifestations in inflammatory rheumatic diseases. J Rheumatol 2005; 64 (1): 12-7.
29. Roman MJ, Shanker BA, Davis A et al. Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus. N Engl J Med 2003; 349 (25): 2399-2406.
30. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46 (4): 1019-27.
31. Asherson RA, Cervera R, de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12 (7): 530-4.
32. Jerrold S, Levine WBJR. The antiphospholipid syndrome. New England Journal of Medicine 2002; 346 (10): 752-63.
33. Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72 (2): 113-24.
34. Sant SM, Tormey VJ, Freyne P, Casey EB. Lymphatic obstruction in rheumatoid arthritis. Clin Rheumatol 1995; 14 (4): 445-50.
35. Kiely PD, Bland JM, Joseph AE et al. Upper limb lymphatic function in inflammatory arthritis. J Rheumatol 1995; 22 (2): 214-7.
36. Minari C, Cecconami L, Fioravanti A et al. Lymphoedema of the limbs in rheumatoid arthritis. Clin Rheumatol 1994; 13 (3): 464-9.
37. Gschwind C, Pfeiffer KM. Rheumatoid lymphoedema: a case report. J Hand Surg Am 1993; 18 (6): 992-4.
38. Joos E, Bourgeois P, Famaey JP. Lymphatic disorders in rheumatoid arthritis. Semin Arthritis Rheum 1993; 22 (6): 392-8.
39. Grillet B, Dequeker J. Rheumatoid lymphoedema. J Rheumatol 1987; 14 (6): 1095-7.
40. Bardare M, Falcini F, Hertzberger-ten CR, Savolainen A, Cimaz R. Idiopathic limb oedema in children with chronic arthritis: a multicentre report of 12 cases. J Rheumatol 1997; 24 (2): 384-8.
41. Grillet B, Dequeker J. Rheumatoid lymphedema. J Rheumatol 1987; 14 (6): 1095-7.
42. Joos E, Bourgeois P, Famaey JP. Lymphatic disorders in rheumatoid arthritis. Semin Arthritis Rheum 1993; 22 (6): 392-8.
43. Minari C, Cecconami L, Fioravanti A, Montemerani M, Scola C, Marcolongo R. Lymphoedema of the limbs in rheumatoid arthritis. Clin Rheumatol 1994; 13 (3): 464-9.
44. Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72 (2): 113-24.
45. Gabbay E, Tarala R, Will R et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997; 156 (2 Pt 1): 528-35.
46. Doyle JJ, Eliasson AH, Argyros GJ et al. Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis. Clin Rheumatol 2000; 19 (3): 217-21.
47. Norman D, Piecyk M, Roberts DH. Eosinophilic pneumonia as an initial manifestation of rheumatoid arthritis. Chest 2004; 126 (3): 993-5.
48. John J Cush, Avthnr Kavan aryh, C. Michael Stein. Rheumatology, Diagnosis and therapeutics, 2nd ed., Philadelphia, Lippincott Williams and Wilkins, 2005; 300.
49. Roubey RA. Update on antiphospholipid antibodies. Curr Opin Rheumatol 2000; 12 (5): 374-78.
50. Chowdhry V, Kumar N, Lachance DH et al. An unusual presentation of rheumatoid meningitis. J Neuroimaging 2005; 15 (3): 286-8.
51. Lamy T. Autoimmune neutropenias. Rev Prat 2001; 51 (14): 1552-7.
52. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002; 39 (2): 121-7.
53. Kargili A, Bavbek N, Kaya A et al. Eosinophilia in rheumatologic diseases: a prospective study of 1,000 cases. Rheumatol Int 2004; 24 (6): 321-4.
54. Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome. Ann Rheum Dis 2005; 64 (7): 1062-4.
55. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 2001; 30 (4): 217-41.
56. Soo MP, Chow SK, Tan CT et al. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus 2000; 9 (7): 511-4.
57. Samant R, Nadkar MY, Vaidya SS et al. Leprosy: a close mimic in a rheumatology clinic. J Assoc Physicians India 1999; 47 (6): 576-9.
58. Peng SL. Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 2002; 31 (4): 228-47.